Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RBP4 | P02753 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13589980 | 1.00 | L3MBTL1 (0.58) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL14493665 | 1.00 | L3MBTL1 (0.58) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5486305 | 0.97 | L3MBTL1 (0.56) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| Hydrochloric Acid SCHEMBL4712251 | 0.97 | L3MBTL1 (0.61) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| Hydrochloric Acid SCHEMBL4712253 | 0.97 | L3MBTL1 (0.61) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| Hydrochloric Acid SCHEMBL1061966 | 0.97 | L3MBTL1 (0.61) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5562998 | 0.91 | L3MBTL1 (0.51) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL30528314 | 0.89 | ALDH1A1 (0.51) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL18364484 | 0.89 | L3MBTL1 (0.50) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5860019 | 0.89 | ALDH1A1 (0.56) | L3MBTL1PKMALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010598-A | High-glaze-hardness bone china and manufacturing method thereof | 唐山庄信科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| US-12538727-B2 | Treatment liquid for semiconductor with ruthenium | TOKUYAMA CORPORATION (JP) | 2026-01-27 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| US-12378357-B2 | Polyamides and corresponding polymer compositions and articles | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2025-08-05 | — | — | US | claimed |
| US-12359076-B2 | Water-soluble resin for printing | KAO CORPORATION (JP) | 2025-07-15 | — | — | US | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| WO-2024232872-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2024-11-14 | — | — | WO | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| WO-2005073272-A1 | IMIDE-MODIFIED POLYESTER RESINS AND METHODS OF MAKING THE SAME | WELLMAN, INC. (US) | 2005-08-11 | — | — | WO | claimed |
| US-20050171326-A1 | Methods of making imide-modified polyester resins | DAK AMERICAS MISSISSIPPI INC. | 2005-08-04 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0567279-B1 | Laminated polyester film and magnetic recording medium using it as base film | TEIJIN LTD (JP) | 1996-12-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12538727-B2 | Treatment liquid for semiconductor with ruthenium | ROS1, HAO2, SCO2 | L3MBTL1 315/4885PKM 3773/4885ALDH1A1 1545/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | L3MBTL1 598/4885PKM 2870/4885ALDH1A1 1569/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | L3MBTL1 1805/4885PKM 1303/4885ALDH1A1 3451/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | L3MBTL1 4695/4885PKM 3579/4885ALDH1A1 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.